These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1101 related articles for article (PubMed ID: 18569917)

  • 21. Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients.
    Lin X; Lin A; Ni Z; Yao Q; Zhang W; Yan Y; Fang W; Gu A; Axelsson J; Qian J
    Nephrol Dial Transplant; 2010 Jul; 25(7):2322-7. PubMed ID: 20118483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk factors associated with survival in patients in a peritoneal dialysis program].
    Sancho A; Pérez Ruixo JJ; Górriz JL; Miguel A; García Ramón R; Avila A
    Nefrologia; 2001; 21(2):160-6. PubMed ID: 11464649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis.
    Rivara MB; Ravel V; Kalantar-Zadeh K; Streja E; Lau WL; Nissenson AR; Kestenbaum B; de Boer IH; Himmelfarb J; Mehrotra R
    J Am Soc Nephrol; 2015 Jul; 26(7):1671-81. PubMed ID: 25613037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival.
    Bechtel JF; Detter C; Fischlein T; Krabatsch T; Osswald BR; Riess FC; Scholz F; Schönburg M; Stamm C; Sievers HH; Bartels C
    Ann Thorac Surg; 2008 Jan; 85(1):147-53. PubMed ID: 18154800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.
    Bell M; Granath F; Schön S; Löfberg E; ; Ekbom A; Martling CR
    Crit Care Med; 2008 Oct; 36(10):2773-8. PubMed ID: 18766088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
    Okuno S; Ishimura E; Kohno K; Fujino-Katoh Y; Maeno Y; Yamakawa T; Inaba M; Nishizawa Y
    Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.
    Hakemi MS; Golbabaei M; Nassiri A; Kayedi M; Hosseini M; Atabak S; Ganji MR; Amini M; Saddadi F; Najafi I
    Iran J Kidney Dis; 2010 Jan; 4(1):44-9. PubMed ID: 20081304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
    Lacson E; Wang W; Hakim RM; Teng M; Lazarus JM
    Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?
    Tentori F; Hunt WC; Rohrscheib M; Zhu M; Stidley CA; Servilla K; Miskulin D; Meyer KB; Bedrick EJ; Johnson HK; Zager PG
    J Am Soc Nephrol; 2007 Aug; 18(8):2377-84. PubMed ID: 17634440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates affecting survival in chronic hemodialysis patients: the combined impact of albumin and high hemoglobin levels on improving outcomes, local and national results.
    Capelli JP; Kushner H
    Hemodial Int; 2008 Oct; 12(4):450-62. PubMed ID: 19090868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.
    Liberek T; Renke M; Skonieczny B; Kotewicz K; Kowalewska J; Chmielewski M; Kot J; Lichodziejewska-Niemierko M; Rutkowski B
    Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease.
    Kovesdy CP; Trivedi BK; Kalantar-Zadeh K; Anderson JE
    Nephrol Dial Transplant; 2006 May; 21(5):1257-62. PubMed ID: 16421161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis.
    Lin-Tan DT; Lin JL; Wang LH; Wang LM; Huang LM; Liu L; Huang JY; Huang YL
    J Am Soc Nephrol; 2007 Aug; 18(8):2385-91. PubMed ID: 17599971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.
    Liao CT; Chen YM; Shiao CC; Hu FC; Huang JW; Kao TW; Chuang HF; Hung KY; Wu KD; Tsai TJ
    Nephrol Dial Transplant; 2009 Sep; 24(9):2909-14. PubMed ID: 19225016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.